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ABSTRACT: Haloalkane dehalogenase from Xanthobacter autotrophicus GJ 10 catalyzes the conversion of 
1,Zdichloroethane to 2-chloroethanol and chloride without use of oxygen or cofactors. The active site is 
situated in an internal cavity, which is accesible from the solvent, even in the crystal. Crystal structures 
of the dehalogenase enzyme complexed with iodoacetamide, chloroacetamide, iodide, and chloride a t  pH 
6.2 and 8.2 revealed a halide binding site between the ring NH's of two tryptophan residues, Trp-125 and 
Trp-175, located in the active site. The halide ion lies on the intersection of the planes of the rings of the 
tryptophans. The binding of iodide and chloride to haloalkane dehalogenase caused a strong decrease in 
protein fluorescence. The decrease could be fitted to a modified form of the Stern-Volmer equation, 
indicating the presence of fluorophors of different accessibilities. Halide binding was much stronger at  pH 
6.0 than a t  pH 8.2. Assuming ligand binding to Trp-125 and Trp-175 as the sole cause of fluorescence 
quenching, dissociation constants a t  pH 6.0 with chloride and iodide were calculated to be 0.49 f 0.04 and 
0.074 f 0.007 mM, respectively. Detailed structural investigation showed that the halide binding site 
probably stabilizes the halide product as well as the negatively charged transition state occurring during 
the formation of the covalent intermediate. 
Haloalkane dehalogenase fromXanthobacter autotrophicus 
GJlO is a globular a/@ protein that converts 1-haloalkanes 
to the corresponding alcohols and a halide ion, without use 
of oxygen or cofactors (Keuning et al., 1985; Janssen et al., 
1989; Franken et al., 1991). Substrates for the enzyme are 
methyl chloride, ethyl chloride, 1,2-dichloroethane, 1,2- 
dibromoethane, and other environmental pollutants (Keuning 
et al., 1985). The three-dimensional structure of the enzyme 
has been elucidated by Franken et al. (1991) using X-ray 
crystallography. The catalytic residues were proposed to be 
Asp-124, His-289, and Asp-260, which are located in an 
internal cavity. This cavity is about 37 A3 in size (1 A = 0.1 
nm) and is lined with hydrophobic residues. Even in the crystal 
the cavity must be reachable from the solvent, because 
[Au(CN)z]-, used as a heavy atom derivative in the structure 
determination, was found to bind in this cavity after soaking 
thecrystalsina solutionofthe heavy atomcompound (Franken 
et al., 1991). The proposed reaction mechanism proceeds in 
twosteps (Frankenet al., 1991). First, thenegativelycharged 
06, atom of Asp- 124 performs a nucleophilic attack on the C1 
carbon atom of the substrate, resulting in an intermediate 
ester and a halide ion. The aromatic rings of two tryptophans 
that point into the cavity could help stabilize the negatively 
charged transition state as well as the halide ion produced. 
Subsequently, a hydrolytic water molecule, activated by His- 
$ The atomic coordinates of the final models have been deposited with 
the Brookhaven Protein Data Bank [accession numbers IEDA, lEDB, 
lEDC, and 1 EDD for the iodoacetamide-dehalogenase, the chloroac- 
etamide-dehalogenase, the iodideAehalogenase, and the chloride- 
dehalogenase complexes, respectively; Bernstein et al. (1 977)]. 
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289, cleaves this intermediate, releasing the alcohol product 
and restoring the Asp124 side chain (Figure 1). 
Iodoacetamide has been reported to be an inhibitor for the 
dehalogenase (Keuning et al., 1985). However, the absence 
of cysteine residues in the putative active site cavity raised the 
question of what the mechanism of the inhibitory action of 
iodoacetamide could be. Therefore, we studied the interaction 
of iodo- and chloroacetamide with the dehalogenase in more 
detail, both in the crystalline state and in solution. From the 
experiments we report here, it appears that iodo- and 
chloroacetamide are poor substrates for the enzyme and that 
inhibition most probably occurs as a result of the presence of 
halide ions. The soaking experiments clearly revealed a halide 
binding site between the ring nitrogens of the two tryptophans 
located in the active site cavity (Trp-125 and Trp-175). 
To corroborate our crystallographic results, we determined 
the fluorescence of dehalogenase in solution as a function of 
halide concentration. Iodide is widely used as a strong 
quenching agent in protein fluorescence studies (Eftink, 199 1). 
Since halide ions quench tryptophanyl fluorescence, it should 
be possible to determine the binding of halide ions and 
halogenated substrates in the neighborhood of tryptophan 
residues by measuring changes in fluorescence. If the two 
active site cavity tryptophans are involved in halide binding, 
then a strong quenching effect should be expected. The 
fluorescence experiments presented here show that this is 
indeed the case, in complete agreement with the crystallo- 
graphic results. 
MATERIALS AND METHODS 
Materials. For the crystallization and soaking experiments, 
ammonium sulfate, iodoacetamide, chloroacetamide, potas- 
sium iodide, and sodium chloride were used without any further 
purification. For the activity and fluorescence measurements, 
0 1993 American Chemical Societv 
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FIGURE 1: Proposed reaction mechanism of haloalkane dehalogenase from X. autotrophicus GJlO (based on Franken et al. (1991) and the 
results of the present study). 
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Quality of the Final Model 
number of residues 1-310 1-310 1-310 1-310 
number of solvent molecules 214 192 130 172 
overall B factor (AZ) 14.3 12.2 11.6 11.8 
final R factoF (%) 16.5 16.9 17.2 16.8 
estimated coordinate erroP (A) 0.13 0.1 1 0.13 0.17 
rms deviations from ideality for 
B factor of the halide ion (AZ) 13.9 6.0 10.2 1 .o 
bond lengths (A) 0.009 0.009 0.01 1 0.01 1 
bond angles (deg) 2.9 2.8 3.2 2.9 
a Intensities whichdeviated toomuch (more than 3afrommeanintensities) or werenegative. R-(%) = [Eh&.&(hk/d) - 7 ( h k r ) l ] / [ G k , E ~ " ~ ( h k ~ d ) I ]  
X 100. c R  factor (%) = [cIIFobI - lFfalcll]/EIFobl X 100. Derived from a UA plot (Read, 1986). 
chloroacetamide and iodoacetamide were recrystallized from 
water to remove contaminating halide. 
Crystallization and Soaking Experiments. Purified ha- 
loalkane dehalogenase fromX. autotrophicus GJlO (Keuning 
et al., 1985) was crystallized by vapor diffuson techniques as 
described before (Rozeboom et al., 1988), after an extra 
purification step on a Mono Q ion-exchange column had been 
performed. 
All soaking experiments were carried out at  room tem- 
perature. Native dehalogenase crystals were soaked for 2 
days in a mother liquor of a 62% saturated (at 0 "C) solution 
of ammonium sulfate in 100 mM bis-Tris-HzS04 buffer of 
pH 6.2, containing 5 mM iodoacetamide, 5 mM chloroace- 
tamide, 5 mM potassium iodide, or 10 mM sodium chloride, 
respectively. For the latter two soaking trials, the pH of the 
mother liquor was raised to pH 8.2. All soaked crystals were 
isomorphous with the native dehalogenase crystals (space 
group P21212), and the soaking with the different compounds 
had a negligible effect on the unit cell dimensions [a = 94.8 
A, b = 72.8 A, c = 41.4 A; Franken et al. (1991)l (Table I). 
Diffraction Data Collection. All data were collected at  
room temperature on an Enraf Nonius FAST area detector 
system (Enraf Nonius, Delft, TheNetherlands). Thedetector 
was equipped with a CAD4 K-goniostat with graphite- 
monochromatized Cu Ka! radiation from an Elliot GX21 
rotating anode X-ray generator. The MADNES package 
(Messerschmidt & Pflugrath, 1987) was used for data 
collection and processing. Profile fitting and local scaling of 
thedata sets weredoneaccording to Kabsch (1988). Merging 
of the data was performed using software from the Groningen 
BIOMOL crystallographic package. More details of the data 
processing are shown in Table I. 
Crystallographic Refinement. The four dehalogenase 
complexes were refined using the TNT package (Tronrud et 
al., 1987). The starting models for all four complexes were 
the refined 1.9-A native atomic coordinates of the enzyme at  
pH 6.2 (Verschueren et al., 1993a). All solvent molecules 
were deleted from the starting model to avoid model bias with 
respect to the halide ions. The TNT suite of programs was 
adapted, whenever necessary, in order to implement the 
scattering factors of the iodide ion (Lee, 1969). 
Alternating cycles of coordinate and temperature factor 
refinement and manual rebuilding on a PS390 Evans and 
Sutherlands graphics system were performed with the pro- 
grams FRODO (Jones, 1978) and 0 (Jones et al., 1991), 
using UA weighted (Read, 1986) (2mlF,,bl- D1Fa& exp(ia!,lc) 
Halide Binding Site in Haloalkane Dehalogenase 
electron density maps. A halide atom was built in the 
respective models only when a density peak in an JFo~l- 
(complex) - IFobsl(native) difference Fourier was consistently 
higher than 10a above the background level. 
Dehalogenase Assays. Dehalogenase activities were de- 
termined as described previously (Keuning et al., 1985). For 
the determination of kinetic constants, the enzyme was 
incubated with varying concentrations of substrate and halide 
ion release was followed using a colorimetric assay (Bergmann 
& Sanik, 1957). 
Fluorescence Measurements. The binding of halide ions 
was followed by steady-state fluorescence measurements at  
25 OC on a SLM Aminco SPF5OO-C spectrofluorometer. 
Dehalogenase (1 pM) was dissolved in TEM buffer (50 mM 
Tris-HzS04 (pH 8.2) containing 1 mM EDTA and 1 mM 
8-mercaptoethanol) or PEM buffer (50 mM NaH2P04- 
NaOH (pH 6.0) containing 1 mM EDTA and 1 mM 
P-mercaptoethanol). The excitation wavelength was 290 nm, 
and spectra were recorded in the range of 300-500 nm. For 
quenching experiments, halides were added from stock 
solutions freshly prepared in the same buffer as the enzyme. 
The decrease in fluorescence was corrected for dilution, which 
did not exceed 10%. 
Fluorescence quenching data were analyzed with the Stern- 
Volmer equation ( l ) ,  which assumes dynamic quenching and 
describes the ratio of unquenched fluorescence (Fo) to the 
remaining fluorescence (F) as a function of the concentration 
of the quenching agent (EL]) and the Stern-Volmer quenching 
constant (Ksv) (Eftink, 1991). 
(1) Fo/F = 1 + Ksv[L] 
Data were also analyzed with the modified Stern-Volmer 
equation (2), which describes the effect of quencher concen- 
tration on the change of fluorescence in the case of a protein 
with two classes of fluorophores, of which a fraction fa is 
accessible to the quenching agent and is quenched with a 
Stern-Volmer constant of KSV (Lehrer, 1971). 
If quenching is caused by binding of a ligand to a single 
fluorescent group and the dissociation constant of the ligand 
and the protein is much larger than the concentration of ligand 
binding sites, a plot of Fo/(Fa - F) vs 1/[L] can be used to 
estimate the association constant (Ka) (Ward, 1985). The 
plot has a slope of Fo/(AFmaxKa) and an intercept of Fo/ 
AFmxr in which A F m a x  is the difference in fluorescence between 
the free and the ligand-saturated protein. The plot has the 
same form as that of eq 2, with Ksv corresponding to Ka. The 
dissociation constants were calculated using a spreadsheet 
program with linear regression or the ENZFITTER program 
of Leatherbarrow (1987). 
RESULTS 
In the course of our studies on the interaction of halo- 
acetamides and halide ions with dehalogenase, four different 
complexes of the enzyme were solved by X-ray crystallography. 
Table I lists the pertinent statistics of the crystallographic 
refinement of these complexes. The final R factors and 
maximum resolutions for the four complexes were 16.5% 
(2.2-A resolution) for the iodoacetamide-dehalogenase com- 
plex, 16.9% (2.0 A) for the chloroacetamide-dehalogenase 
complex, 17.2% (2.3 A) for the iodide-dehalogenase complex, 
and 16.8% (2.1 A) for the chloride-dehalogenase complex, 
respectively. The mean positional errors in atomic coordinates 
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FIGURE 2: (a, top) IF,bl(chloroacetamide) - IF,bl(native) difference 
Fourier, showing the electron density of the chloride ion situated in 
the active site cavity of the dehalogenase-chloroacetamide complex. 
The tryptophan residues, the catalytic triad, and the hydrolytic water 
molecule (H20 nucl) are shown with thicker lines. Crosses indicate 
the positions of water molecules. The lF,bl(chloride) - JF,bJ(native) 
difference map is virtually the same. (b, bottom) IF,bl(iodide) - 
JF,bl(native) difference Fourier, showing the electron density of the 
iodide ion in theactive sitecavity of the dehalogenaseiodide complex. 
The IF,bl(iodoacetamide) - IF,kl(native) difference map is virtually 
the same. 
for the complexes were estimated from UA plots (Read, 1986) 
to be around 0.15 A. Further details about the refinement 
statistics are listed in Table I. 
Iodoacetamide-Dehalogenase Complex. Since iodoacet- 
amide was reported to be an inhibitor of the haloalkane 
dehalogenase (Keuning et al., 1985), we started the soaking 
experiments with this compound, aiming to elucidate the 
inhibition mechanism. Soaking native dehalogenase crystals 
in a 5 mM iodoacetamide solution of pH 6.2 revealed a large 
spherical electron density located between the two tryptophans 
(Trp-125 and Trp-175) in the active site cavity. Both an 
IF,bl(iodoacetamide) - IF,b,l(native) difference Fourier and a 
UA weighted (Read, 1986) mlF,bl(iodoacetamide) - DIFalcl- 
(native) difference map showed one clear single difference 
peak at the level of over 30a above background, consistent 
with an iodide ion. No clear density could be seen for the 
acetamide moiety of the compound. From these results, we 
conclude that an iodide ion is bound in the active site. It is 
firmly stabilized by the side-chain NH’s of the two tryptophan 
aromatic rings (Figure 2b). Table I1 summarizes the distances 
of the iodide ion to the neighboring atoms in the cavity. No 
other clear difference density could be observed, indicating 
that no other reaction sites for iodoacetamide are present in 
the dehalogenase molecule. The four cysteine residues in the 
structure also showed no additional electron density, thereby 
excluding the earlier assumption that iodoacetamide could 
inhibit the dehalogenase by modification of one or more 
cysteines in the enzyme (Keuning et al., 1985). 
Chloroacetamide-Dehalogenase Complex. A result very 
similar to that with the iodoacetamide was obtained by soaking 
native dehalogenase crystals in a 5 mM chloroacetamide 
solution at  pH 6.2. Also in this case, spherical density for a 
chloride ion was found in the active site cavity, being the only 
peak a t  a level of 11 a in an  IF,b,)(chloroacetamide) - 
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Table 11: Distances of the Halide Ion in the Complexes to Its Neighboring Non-Carbon Atoms (15.0 A) 
iodoacetamide-dehalogenase chloroacetamide-dehalogenase iodide-dehalogenase chloride4ehalogenase 
distance to C1- (A) distance to I- (A) distance to Cl- (A) atom of dehalogenase distance to I- (A) 
Trp-125 N,, 3.7 3.4 3.6 3.4 
Trp-175 Ne, 3.4 3.2 3.4 3.3 
Asp- 124 Oa, 4.8 4.6 5.0 
ASP- 124 08, 4.1 4.8 4.6 4.8 
Phe-222 0 4.3 3.9 4.2 4.0 
Pro-223 N 3.9 3.5 4.0 3.6 
H20 3.4 3.2 3.3 3.2 
Table 111: Hydrolysis of Haloacetamides by Haloalkane 
Dehalogenase" 
1,2-dichloroethane 0.68 f 0.07 4.5 f 0.3 (3.8 & 0.7) X lo3 
chloroacetamideb > 100 >0.08 
bromoacetamide 63 f 7 0.83 f 0.08 7.7 f 1.6 
iodoacetamide 58 f 7 0.40 f 0.1 4.0 f 1.5 
Dehalogenase assays were performed by measuring halide release at 
pH 8.2. Chloroacetamide dehalogenase activities increased linearly up 
to concentrations of 100 mM, above which substrate inhibition occurred. 
IF,t,,l(native) difference Fourier. This chloride ion was also 
stabilized between the ring nitrogens of Trp-125 and Trp-175 
and was nearly lying in the plane of the two tryptophan side 
chains (Figure 2a). Likewise, we could not observe any 
additional density for the acetamide part of the reagent. The 
distances of the chloride ion to its neighboring atoms are listed 
in Table 11. 
Chloride-Dehalogenase and Iodide-Dehalogenase Com- 
plexes. To confirm that the halide binding site in the active 
site cavity in the dehalogenase structure also exists at pH 8.2, 
the pH at which the enzyme reaches its optimal activity, two 
other soaking experiments were performed with the native 
dehalogenase crystal in a 10 mM sodium chloride and a 5 mM 
potassium iodide solution at this pH. Again, in both complexes 
a spherical electron density appeared between the two 
tryptophans on IF,hl(chloride) - IF,hl(native) and IF,hl(iodide) 
- IF,b,((native) difference Fouriers (Figure 2), which were 
24a and 30a above background, respectively, indicating that 
at pH 8.2 also a halide ion can be bound in the active site 
cavity. The halides are bound at the same position as in the 
complexes with chloroacetamide and iodoacetamide. The 
atoms surrounding these chloride and iodide ions with their 
distances are given in Table I1 and appear, within the estimated 
error limit, to be identical to the atoms interacting with the 
chloride and halide ions from the haloacetamides. 
Hydrolysis of Haloacetamides. To investigate whether 
the halide binding observed in the crystal structures of the 
dehalogenase soaked in haloacetamides was due to contam- 
inating halide ions present in the haloacetamide solution, or 
whether the enzyme hydrolyzes the haloacetamides producing 
the halide ions, we determined the catalytic activity of the 
enzyme on purified haloacetamides. From Table 111, it is 
clear that dehalogenase catalyzes the release of halide ions 
from chloroacetamide, bromoacetamide, and iodoacetamide. 
The activity with chloroacetamide was very low. A Km value 
could not be determined since it was above 100 mM, a 
concentration at which substrate inhibition occurred. The 
K m  values with bromoacetamide and iodoacetamide were 
around 60 mM, which is much higher than with 1,2- 
dichloroethane, and the V,,, was lower. As a result, the 
specificity constant ( kcat/Km) of the enzyme for haloacetamides 
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FIGURE 3: Quenching of haloalkane dehalogenase fluorescence by 
acrylamide. Measurements were done at pH 8.2 in 50 mM Tris- 
HzS04 buffer. The fluorescence is plotted as the reciprocal of the 
fraction of unquenched fluorescence (eq 1, Stern-Volmer plot). The 
inset shows the modified Stern-Volmer plot (eq 2). 
Fluorescence Quenching. Haloalkane dehalogenase con- 
tains six tryptophan residues, of which two are located in the 
active site cavity. Using fluorescence measurements, we have 
studied the binding of halide ions to the enzyme. When 
dissolved in 50 mM Tris buffer at pH 8.2, the dehalogenase 
showed an emission maximum at 346.5 nm, which is typical 
of tryptophanyl fluorescence. The quenching of dehalogenase 
fluorescence caused by acrylamide followed the simple Stern- 
Volmer relationship (eq 1, Figure 3).  Acrylamide is a polar 
nonionic quencher that has access to all but the most buried 
residues. The linear increase of Fo/F with increasing acryl- 
amide concentrations and the value of the Stern-Volmer 
constant KSV indicate that all six tryptophan residues are 
relatively well accessible to acrylamide (Eftink & Ghiron, 
1976). 
Addition of iodide at different concentrations to a solution 
of dehalogenase in Tris buffer at pH 8.2 caused a decrease 
in fluorescence (Figure 4). As with acrylamide, there was no 
shift of the emission maximum, indicating that the hydro- 
phobicity of the environment of the fluorescent groups did not 
change. Iodide is a large polar anion considered to have access 
only to surface tryptophans. The quenching data obtained 
with a range of iodide concentrations at pH 8.2 (Tris buffer) 
or pH 6.0 (phosphate buffer) (Figure 5) could not be fitted 
with the Stern-Volmer equation (1). The modified Stern- 
Volmer equation (2) did fit the experimental data (Figure 5, 
insets), indicating the presence of fluorophores of different 
accessibility to iodide ions. The fractional accessibility of 0.5 
calculated from these plots is higher than expected if only the 
fluorescence of the two cavity-exposed tryptophan residues 
would be quenched. 
Chloride ions caused a similar quenching of fluorescence, 
although higher concentrations were needed. Again, data 
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FIGURE 4: Effect of iodide on the steady-state fluorescence emission 
spectrum of haloalkane dehalogenase. Spectra were recorded at pH 
8.2 in TEM buffer as described under Materials and Methods. 
could only be fitted to the modified Stern-Volmer equation 
(2), which gave a fractional accessibility of 0.34 and a higher 
quenching constant at  pH 6.0 than at  pH 8.2 (Figure 5). The 
fa values obtained with chloride are in agreement with two of 
the six tryptophans being quenched. 
If it is assumed that quenching is caused only by binding 
of halide ions to the active site tryptophans, then the Stern- 
Volmer constant in eq 2 corresponds to an association constant 
between ligand and fluorophore (Ward, 1985). The disso- 
ciation constants (Kd) (Table IV) show that iodide binds 
stronger than chloride and that binding at pH 6 is stronger 
than at  pH 8.2. 
DISCUSSION AND CONCLUSION 
Conuersion of Haloacetamides. To investigate the previ- 
ously reported inhibitory action of iodoacetamide on the 
activity of haloalkane dehalogenase (Keuning et al., 1985), 
we elucidated the crystal structures of the enzyme complexed 
with haloacetamides. The soaking experiments with iodoac- 
etamide and chloroacetamide at  pH 6.2 did not cause 
significant structural changes in the protein molecule. The 
residues surrounding the active site retain the native confor- 
mation and are not disrupted upon binding the compound. 
This rules out a conformational change as a possible cause for 
the reported inhibition by iodoacetamide. The four cysteine 
residues in the enzyme structure are also not affected. We 
could not observe modified electron densities of these residues 
upon binding. Moreover, the nearest cysteine (Cys-150) is 
8.5 A away from the putative active site cavity and is shielded 
from the cavity by the side chain of Phe-128 (Franken et al., 
1991). 
The soaking results, however, clearly indicated the binding 
position of a halide ion, one of the products of the reaction 
catalyzed by the haloalkane dehalogenase. The halide ion is 
firmly stabilized in the internal active site cavity between two 
tryptophan aromatic rings (Trp-125 and Trp-175) which point 
with their side chains into the cavity. Kinetic results indicated 
that purified haloacetamides act more as poor substrates than 
as inhibitors. They are converted at  a low rate by the purified 
dehalogenase. Since dehalogenase in the crystalline state is 
active (Verschueren et al., 1993b), this could account for the 
presence of the halide ion in the active site cavity, the more 
so because the soaking and data collection were done over a 
period of 4 days. Nevertheless, we cannot rule out the 
alternative explanation that the presence of a halide ion in the 
active site cavity is due to contamination of the soaking solution 
by these ions. Differences in substrate purity or the lower pH 
used in previous assays might also explain the previously 
reported inhibitory effect of iodoacetamide on the activity of 
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the enzyme (Keuning et al., 1985). At pH 7.5, halide ions 
that contaminate the chemically labile substrate are bound 
stronger and thus will be more efficient inhibitors than at pH 
8.2 (see below). 
Binding Site for  Halides between the Two Tryptophans of 
the Active Site Cauity. The crystallographic results obtained 
from the soaking experiments of haloalkane dehalogenase 
crystals with halides clearly indicated a halide binding site 
between the two tryptophan residues (Trp- 125 and Trp- 175) 
in the active site cavity. The fluorescence quenching data are 
in agreement with these results. The cavity contains two of 
the six tryptophan residues present in the enzyme. Proteins 
are considered to be poorly penetrated by the negatively 
charged halide ions, allowing only quenching of the fluores- 
cence of solvent-exposed groups by a collision mechanism. 
The fractional accessibility cfa) values obtained for chloride 
at pH and 6.0 and 8.2 indicate that only two tryptophans are 
accessible, most probably the ones in the active site. The 
iodide ion quenching data suggest that three out of six 
tryptophan residues are accessible. Analysis of the position 
of the tryptophans in the three-dimensional structure of the 
dehalogenase shows that Trp- 194 is also somewhat accessible. 
Alternatively, the higher apparent accessibility to iodide could 
indicate that the two tryptophan residues in the cavity make 
a greater contribution to the total protein fluorescence than 
the expected 33%, in which case chloride would not completely 
abolish fluorescence. 
Assuming halide binding as the cause of fluorescence 
quenching, this change of fluorescence can be used to determine 
dissociation constants and stoichiometries of ligand binding 
(Ward, 1985). At pH 6.0 thedissociationconstants for halide 
ions are much lower than at pH 8.2. The most likely 
explanation for this observation is that in native dehalogenase, 
without halides bound, the active site His-289 is positively 
charged at  pH 6.0, but is neutral at  pH 8.2 (Verschueren et 
al., 1993a). Since the halide ion in the active site binds in the 
neighborhood of His-289 and of the negatively charged Asp- 
124 side chain, the binding at  low pH with a positive charge 
on the His-289 side chain will be more favorable than at  high 
Iodide ions are bound more strongly than chloride ions. 
Likewise, the Km for iodoacetamide is lower than that for 
chloroacetamide. Although both compounds are poor sub- 
strates, it thus appears that interactions between the halogen 
and the tryptophans in the active site contribute considerably 
to substrate binding. 
Mode of Binding of the Halide Ion between the Tryp- 
tophans. In the crystal structure no obvious positively charged 
group is found in the vicinity of the negatively charged halide 
ion. The halide ion is stabilized in the nonpolar, hydrophobic 
environment of the cavity. From the earlier studies of Swaney 
and Klotz (1970) performed on serum albumin it was already 
proposed that a cluster of nonpolar residues including a 
tryptophan residue can offer a very favorable environment for 
binding small anions. The hydrogen atoms bound to the ring 
nitrogens of the two tryptophans, Trp-125 and Trp-175, in 
the cavity of dehalogenase have a slightly positive charge which 
facilitates positioning of the negatively charged halide ion 
between the two nitrogen atoms. In addition, the bound anion 
may be stabilized by nonpolar interactions in the cavity. 
Whereas positively charged groups areoften stabilized through 
van der Waals contact with the .rr-electron cloud of aromatic 
rings and are therefore located above or below the ring 
(Tiichsen & Woodward, 1987; Burley & Petsko, 1988; 
Kooystra et al., 1988; Perutz et al., 1986), negatively charged 
PH. 
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FIGURE 5 :  Effect of halide ions on the fluorescence of haloalkane dehalogenase: (A) iodide, pH 8.2; (B) iodide, pH 6.0; (C) chloride, pH 
8.2; (D) chloride, pH 6.0. Fluorescence was measured in Tris buffer (pH 8.2) or phosphate buffer (pH 6.0) as described in the Materials 
and Methods. Stern-Volmer plots are shown (eq l), with plots of the modified Stern-volmer equation in the insets (eq 2). 
groups are preferentially located in the plane of the aromatic 
ring, interacting with the somewhat positively charged 
aromatic hydrogen atoms. Thomas et al. (1982) have 
presented such an electrostatic interaction between a negatively 
charged oxygen and the positively charged aromatic ring 
hydrogens of a phenylalanine side chain, accompanied by a 
repulsion of the oxygen by the electron-ring ?r-cloud of the 
aromatic ring. This has also been observed for the sulfur- 
aromatic interactions in proteins (Reid, 1985), where, of 36 
proteins examined, almost half of the electronegative sulfur 
atoms of the cysteine and methionine residues exhibited affinity 
toward the edge of the planar aromatic rings. The occurrence 
of these electrostatic interactions between residues in proteins 
suggests that interactions of polar groups with aromatic rings 
contribute to protein stability (Burley & Petsko, 1988; Reid, 
1985). 
The results obtained from the soaking experiments with 
halides and halide compounds strongly suggest that haloalkane 
dehalogenase uses the same kind of electrostatic stabilization 
for the interaction of the side chains of the two tryptophans 
in the active site cavity, Trp-125 and Trp-175, with the 
negatively charged halide product. Moreover, the aromatic 
rings of these two tryptophans are positioned in such a way 
that they even may contribute to the stabilization of the 
putative negatively charged transition state in the first step 
of the reaction pathway of the dehalogenase. The transition 
state for this step has been proposed to be a pentacoordinated 
Table IV: Quenching Constants (K~v), Fractional Accessibilities 
ua), and Dissociation Constants (Kd) of Halides 
quenching 
agent PH fa KsP (M-') Kd (mM) 
acrylamide 8.2 1.0 f 0.1 4.2 f 0.2 
chloride 6.0 0.34 f 0.01 (2.1 f 0.2) X lo3 0.49 f 0.04 
iodide 6.0 0.49 f 0.01 (14.8 f 1.4) X lo3 0.074 f 0.007 
chloride 8.2 0.35 0.01 17 & 0.1 57*3 
iodide 8.2 0.49 f 0.01 202 f 12 5.0 0.3 
a Quenchingconstants werecalculated from thestem-Volmer equation 
(acrylamide, eq 1, Figure 3) or the modified Stern-Volmer equation 
(halides, eq 2, Figure 5 ) ,  using least-squares fits. 
carbon atom with a negative charge developing on the halogen 
atom that is covalently bound to this carbon (Franken et al., 
1991). The interaction of the halogen atom with the 
tryptophans might lower the transition-state energy and thus 
facilitate the formation of a covalently bound intermediate 
(Figure 1). 
Site-directed mutagenesis experiments on Trp- 125 and Trp- 
175 in the active site cavity could add extra information on 
the role of these tryptophans in the reaction mechanism of 
haloalkane dehalogenase. 
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